ConductScience.org, home

Trial · NCT04180982

A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia

NCT04180982, Phase 2, Unknown, Jiangsu HengRui Medicine Co., Ltd.

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia. Trials, record NCT04180982. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04180982

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia
NCT number
NCT04180982
Status
Unknown
Phases
Phase 2
Enrollment
84 participants, estimated
Lead sponsor
Jiangsu HengRui Medicine Co., Ltd.
Conditions
Hyperuricemia
Interventions
SHR4640 dose1 plus Febuxostat dose1, SHR4640 dose1 plus Febuxostat dose2, SHR4640 dose2 plus Febuxostat dose3
First posted
2019-11-29
Last updated
2019-12-02

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryAdverse Events(AEs) and Serious Adverse Events(SAEs)Up to week 4Incidence of AEs and SAEs, incidence of Treatment-Emergent Adverse Events, incidence of drug related adverse events (safety and tolerability)
SecondaryPercentage of subjects with a serum uric level≤360μmol/LAt week1, 2, 3 and 4
SecondaryPercentage change from baseline in serum uric level .At week1, 2, 3 and 4
SecondaryActual change from baseline in serum uric levelAt week1, 2, 3 and 4

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Source

Release
trials-2026-11-12-0.4.0
Release manifest SHA-256
0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
Registry capture
2026-11-12
Results copy, AACT
2026-03-23
NIH clinical studies file
2026-11-13

Source ClinicalTrials.gov

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04180982

GET https://conductscience.org/api/trials/v1/NCT04180982/registered